Moolec Science (MLEC) Amortizatization of Intangibles (2023 - 2024)
Moolec Science (MLEC) reported Amortizatization of Intangibles of $239265.0 for Q4 2024, up 21.85% on a YoY basis from $196354.0 in Q1 2024, and up 0.63% sequentially from $237773.0 in Q3 2024.
Moolec Science (MLEC) Amortizatization of Intangibles (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of Amortizatization of Intangibles data on file, last reported at $239265.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortizatization of Intangibles rose 21.85% year-over-year to $239265.0; the trailing twelve-month figure through Dec 2024 stood at $854066.0 (changed N/A YoY), and the FY2024 full-year result was $713374.0, up 654.76% from the prior year.
- Amortizatization of Intangibles climbed to $239265.0 in Q4 2024, from $237773.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $239265.0 in Q4 2024 to a low of $139992.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 239,265.00 |
| Dec 31, 2024 | 239,265.00 |
| Sep 30, 2024 | 237,773.00 |
| Sep 30, 2024 | 237,773.00 |
| Jun 30, 2024 | 188,185.00 |
| Jun 30, 2024 | 188,185.00 |
| Mar 31, 2024 | 188,843.00 |
| Mar 31, 2024 | 188,843.00 |
| Dec 31, 2023 | 196,354.00 |
| Dec 31, 2023 | 196,354.00 |
| Sep 30, 2023 | 139,992.00 |
| Sep 30, 2023 | 139,992.00 |